The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

• Status: Unknown status
• Trial end date: 2015-04-01
• Target enrollment: 0
• Participant gender: Female

Summary

This prospective clinical trial evaluates the effect of a two dose GnRH agonist administered in the luteal phase on the outcome of ART cycles stimulated with the long GnRH agonist and GnRH antagonist protocol.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital
• Treatments: Deslorelin; Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Leuprolide; Polyestradiol phosphate; Progesterone; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• Couples undergoing ART with their own gametes.

• Couples having at least one good embryo available for transfer.

• Normoresponder

• Infertility etiology is unexplained

• ovulation triggered by intramuscular injection of 10000 IU of HCG

Exclusion Criteria:

Patients older than 38 years old

• High and poor responder patients